Pediatrix Medical (MD) | Financial Analysis & Statements
Pediatrix Medical Group, Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
493.8M
Gross Profit
126.0M
25.51%
Operating Income
54.7M
11.07%
Net Income
33.7M
6.82%
Balance Sheet Metrics
Total Assets
2.2B
Total Liabilities
1.4B
Shareholders Equity
865.9M
Debt to Equity
1.59
Cash Flow Metrics
Operating Cash Flow
60.2M
Free Cash Flow
108.8M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Pediatrix Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.9B | 2.0B | 2.0B | 2.0B | 1.9B |
| Cost of Goods Sold | 1.4B | 1.6B | 1.6B | 1.5B | 1.4B |
| Gross Profit | 493.7M | 454.3M | 421.6M | 467.0M | 513.2M |
| Gross Margin % | 25.8% | 22.6% | 21.1% | 23.7% | 26.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 240.8M | 238.4M | 227.5M | 231.4M | 263.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 240.8M | 238.4M | 227.5M | 231.4M | 263.4M |
| Operating Income | 231.1M | 183.7M | 157.9M | 200.0M | 217.7M |
| Operating Margin % | 12.1% | 9.1% | 7.9% | 10.1% | 11.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 36.0M | 40.7M | 42.1M | 39.7M | 68.7M |
| Other Non-Operating Income | 21.3M | -244.3M | -164.1M | -78.9M | -13.8M |
| Pre-tax Income | 216.4M | -101.3M | -48.4M | 81.4M | 135.2M |
| Income Tax | 51.0M | -2.3M | 12.0M | 18.8M | 27.2M |
| Effective Tax Rate % | 23.6% | 0.0% | 0.0% | 23.1% | 20.1% |
| Net Income | 165.4M | -99.1M | -60.4M | 66.3M | 130.9M |
| Net Margin % | 8.6% | -4.9% | -3.0% | 3.4% | 6.9% |
| Key Metrics | |||||
| EBITDA | 256.5M | 218.3M | 196.1M | 237.4M | 251.8M |
| EPS (Basic) | $1.97 | $-1.15 | $-0.72 | $0.80 | $1.52 |
| EPS (Diluted) | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.52 |
| Basic Shares Outstanding | 84080000 | 85866000 | 84018023 | 82947000 | 86423000 |
| Diluted Shares Outstanding | 84080000 | 85866000 | 84018023 | 82947000 | 86423000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Pediatrix Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 375.2M | 229.9M | 73.3M | 9.8M | 387.4M |
| Short-term Investments | 124.5M | 118.6M | 104.5M | 93.2M | 99.7M |
| Accounts Receivable | 229.7M | 260.0M | 272.3M | 296.8M | 301.8M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 8.9M | 5.1M | 12.3M | 13.3M | 18.9M |
| Total Current Assets | 763.5M | 639.6M | 483.5M | 428.0M | 840.6M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 195.5M | 194.6M | 278.3M | 302.1M | 290.0M |
| Goodwill | 2.5B | 2.5B | 2.8B | 3.1B | 3.0B |
| Intangible Assets | 16.9M | 11.6M | 21.2M | 18.5M | 21.6M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 132.1M | 180.5M | 185.0M | 229.1M | 219.4M |
| Total Non-Current Assets | 1.5B | 1.5B | 1.7B | 1.9B | 1.9B |
| Total Assets | 2.2B | 2.2B | 2.2B | 2.3B | 2.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 37.2M | 46.4M | 34.6M | 31.9M | 36.6M |
| Short-term Debt | 38.4M | 33.2M | 36.0M | 36.5M | 22.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 458.9M | 434.1M | 388.9M | 427.0M | 427.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 596.2M | 629.1M | 665.7M | 680.6M | 1.0B |
| Deferred Tax Liabilities | 57.0M | 34.2M | 34.3M | 33.6M | 41.4M |
| Other Non-Current Liabilities | 268.7M | 290.3M | 281.8M | 315.0M | 313.4M |
| Total Non-Current Liabilities | 921.9M | 953.7M | 981.8M | 1.0B | 1.4B |
| Total Liabilities | 1.4B | 1.4B | 1.4B | 1.5B | 1.8B |
| Equity | |||||
| Common Stock | 830.0K | 859.0K | 840.0K | 829.0K | 864.0K |
| Retained Earnings | -83.2M | -248.5M | -149.5M | -89.1M | -155.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 865.9M | 764.9M | 849.1M | 891.6M | 896.7M |
| Key Metrics | |||||
| Total Debt | 634.6M | 662.3M | 701.6M | 717.1M | 1.1B |
| Working Capital | 304.6M | 205.5M | 94.5M | 1.0M | 413.2M |
Balance Sheet Composition
Pediatrix Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 165.4M | -99.1M | -60.4M | 62.6M | 108.0M |
| Depreciation & Amortization | 21.8M | 32.2M | 36.2M | 35.6M | 32.1M |
| Stock-Based Compensation | 18.0M | 11.9M | 12.3M | 16.1M | 19.0M |
| Working Capital Changes | 16.4M | 33.6M | -221.0K | 15.5M | -64.9M |
| Operating Cash Flow | 270.2M | -25.5M | -10.8M | 108.9M | 65.0M |
| Investing Activities | |||||
| Capital Expenditures | -18.5M | -22.0M | -33.3M | -29.7M | -7.5M |
| Acquisitions | 6.8M | -8.2M | -6.7M | -28.2M | -29.9M |
| Investment Purchases | -29.9M | -64.5M | -31.9M | -17.3M | -35.1M |
| Investment Sales | 26.7M | 52.5M | 22.9M | 16.9M | 16.5M |
| Investing Cash Flow | -18.3M | -35.4M | -48.2M | -57.0M | -55.4M |
| Financing Activities | |||||
| Share Repurchases | -86.7M | -1.7M | -919.0K | -88.5M | -4.7M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 235.5M | 470.0M | 1.5B | 0 |
| Debt Repayment | -20.8M | -250.9M | -489.1M | -1.9B | -762.7M |
| Financing Cash Flow | -107.5M | -14.5M | -25.7M | -487.6M | -760.1M |
| Free Cash Flow | 252.6M | 184.6M | 104.0M | 137.2M | 44.5M |
| Net Change in Cash | 144.4M | -75.4M | -84.7M | -435.6M | -750.6M |
Cash Flow Trend
Pediatrix Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
11.88
Forward P/E
9.90
Price to Book
2.16
Price to Sales
1.00
PEG Ratio
9.90
Profitability Ratios
Profit Margin
8.64%
Operating Margin
11.07%
Return on Equity
20.28%
Return on Assets
6.57%
Financial Health
Current Ratio
1.66
Debt to Equity
73.29
Beta
0.72
Per Share Data
EPS (TTM)
$1.94
Book Value per Share
$10.68
Revenue per Share
$22.76
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MD | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
| Addus HomeCare | 1.8B | 18.10 | 1.58 | 9.33% | 6.74% | 15.79 |
Financial data is updated regularly. All figures are in the company's reporting currency.






